ClinicalTrials.Veeva

Menu

Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery

A

Azienda Policlinico Umberto I

Status and phase

Unknown
Phase 4

Conditions

Cardiovascular Diseases

Treatments

Drug: Levosimendan
Drug: Dobutamine

Study type

Interventional

Funder types

Other

Identifiers

NCT02012946
levodobu

Details and patient eligibility

About

This study wants to investigate the hemodynamic changes in cardiopatic patients undergoing major non cardiac surgery, during and after the continuous infusion of levosimendan or dobutamine.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • EF < 40%, no liver and renal disfynction, chronic cardiopathy

Exclusion criteria

  • acute coronary syndrome, life expectation <30 days, hemodialysis, ventricular tachycardia/ventricular fibrillation

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

dobutamine
Active Comparator group
Description:
patient receiving dobutamine
Treatment:
Drug: Dobutamine
Levosimendan
Active Comparator group
Description:
patient receiving levosimendan
Treatment:
Drug: Levosimendan

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems